These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3823673)

  • 1. Sample size requirements and the cost of a randomized clinical trial with repeated measurements.
    Bloch DA
    Stat Med; 1986; 5(6):663-7. PubMed ID: 3823673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-function approach to the design of reliability studies.
    Eliasziw M; Donner A
    Stat Med; 1987 Sep; 6(6):647-55. PubMed ID: 3685720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of screening and eliminating preexisting cases on sample size requirements for cancer prevention trials.
    Patterson BH
    Control Clin Trials; 1987 Jun; 8(2):87-95. PubMed ID: 3608509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The net effect of alternative allocation ratios on recruitment time and trial cost.
    Vozdolska R; Sano M; Aisen P; Edland SD
    Clin Trials; 2009 Apr; 6(2):126-32. PubMed ID: 19342464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-designing two-stage trials to minimize expected costs.
    Thach CT; Fisher LD
    Biometrics; 2002 Jun; 58(2):432-8. PubMed ID: 12071417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomization and efficiency in Zelen's single-consent design.
    Matts J; McHugh R
    Biometrics; 1987 Dec; 43(4):885-94. PubMed ID: 3427173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating maximum power losses in survival studies with nonstratified randomization.
    Palta M
    Biometrics; 1985 Jun; 41(2):497-504. PubMed ID: 4027324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planning a clinical trial with allowance for cost and patient recruitment rate.
    Moussa MA
    Comput Programs Biomed; 1984; 18(3):173-9. PubMed ID: 6548679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimize the use of minimization with unequal allocation.
    Proschan M; Brittain E; Kammerman L
    Biometrics; 2011 Sep; 67(3):1135-41. PubMed ID: 21281276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The futility index. An approach to the cost-effective termination of randomized clinical trials.
    Ware JH; Muller JE; Braunwald E
    Am J Med; 1985 Apr; 78(4):635-43. PubMed ID: 3920906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biostatistical methods for demonstrating efficacy in the regulatory setting. An epistemological approach to adaptive designs.
    Koch A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):572-9. PubMed ID: 15887068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The randomized clinical trial.
    Brown BW
    Stat Med; 1984; 3(4):307-14. PubMed ID: 6528130
    [No Abstract]   [Full Text] [Related]  

  • 13. Tests of significance using regression models for ordered categorical data.
    Snapinn SM; Small RD
    Biometrics; 1986 Sep; 42(3):583-92. PubMed ID: 3567291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power, sample size and smallest detectable effect determination for multivariate studies.
    Greenland S
    Stat Med; 1985; 4(2):117-27. PubMed ID: 4023473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A note on the sample size determination in two-period repeated measurements crossover design with application to clinical trials.
    Yue LQ; Roach P
    J Biopharm Stat; 1998 Nov; 8(4):577-84. PubMed ID: 9855035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim analyses for randomized clinical trials: the group sequential approach.
    Pocock SJ
    Biometrics; 1982 Mar; 38(1):153-62. PubMed ID: 7082757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trials: issues for researchers.
    Fetter MS; Feetham SL; D'Apolito K; Chaze BA; Fink A; Frink BB; Hougart MK; Rushton CH
    Nurs Res; 1989; 38(2):117-20. PubMed ID: 2648334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to design a clinical trial.
    Curtis BM; Barrett BJ; Parfrey PS
    Methods Mol Med; 2003; 86():475-89. PubMed ID: 12886789
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive Cohort Study: an alternative to randomized consent design in a breast preservation trial.
    Olschewski M; Scheurlen H
    Methods Inf Med; 1985 Jul; 24(3):131-4. PubMed ID: 4033443
    [No Abstract]   [Full Text] [Related]  

  • 20. A two-stage design for choosing among several experimental treatments and a control in clinical trials.
    Thall PF; Simon R; Ellenberg SS
    Biometrics; 1989 Jun; 45(2):537-47. PubMed ID: 2765637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.